References(90)
[1]
Butovsky, O., Weiner, H. L. Microglial signatures and their role in health and disease. Nature Reviews Neuroscience, 2018, 19(10): 622–635.
[2]
Song, W. M., Colonna, M. The microglial response to neurodegenerative disease. In: Alt, F. (eds.), Advances in Immunology. Amsterdam: Elsevier, 2018: 1–50.
[3]
Färber, K., Kettenmann, H. Purinergic signaling and microglia. Pflügers Archiv - European Journal of Physiology, 2006, 452(5): 615–621.
[4]
Koizumi, S., Ohsawa, K., Inoue, K., Kohsaka, S. Purinergic receptors in microglia: Functional modal shifts of microglia mediated by P2 and P1 receptors. Glia, 2013, 61(1): 47–54.
[5]
Calovi, S., Mut-Arbona, P., Sperlágh, B. Microglia and the purinergic signaling system. Neuroscience, 2019, 405: 137–147.
[6]
Vainchtein, I. D., Molofsky, A. V. Astrocytes and microglia: In sickness and in health. Trends in Neurosciences, 2020, 43(3): 144–154.
[7]
Burnstock, G. Overview: Purinergic mechanisms. Annals of the New York Academy of Sciences, 1990, 603(1): 1–17.
[8]
von Kügelgen, I., Hoffmann, K. Pharmacology and structure of P2Y receptors. Neuropharmacology, 2016, 104: 50–61.
[9]
Färber, K., Kettenmann, H. Physiology of microglial cells. Brain Research Reviews, 2005, 48(2): 133–143.
[10]
Sasaki, Y., Hoshi, M., Akazawa, C., Nakamura, Y., Tsuzuki, H., Inoue, K., Kohsaka, S. Selective expression of Gi/o-coupled ATP receptor P2Y12 in microglia in rat brain. Glia, 2003, 44(3): 242–250.
[11]
Hickman, S. E., Kingery, N. D., Ohsumi, T. K., Borowsky, M. L., Wang, L. C., Means, T. K., El Khoury, J. The microglial sensome revealed by direct RNA sequencing. Nature Neuroscience, 2013, 16(12): 1896–1905.
[12]
Butovsky, O., Jedrychowski, M. P., Moore, C. S., Cialic, R., Lanser, A. J., Gabriely, G., Koeglsperger, T., Ben, D. K., Wu, P. M., Doykan, C. E. et al. Identification of a unique TGF-β–dependent molecular and functional signature in microglia. Nature Neuroscience, 2014, 17(1): 131–143.
[13]
Haynes, S. E., Hollopeter, G., Yang, G., Kurpius, D., Dailey, M. E., Gan, W. B., Julius, D. The P2Y12 receptor regulates microglial activation by extracellular nucleotides. Nature Neuroscience, 2006, 9(12): 1512–1519.
[14]
Davalos, D., Grutzendler, J., Yang, G., Kim, J. V., Zuo, Y., Jung, S., Littman, D. R., Dustin, M. L., Gan, W. B. ATP mediates rapid microglial response to local brain injury in vivo. Nature Neuroscience, 2005, 8(6): 752–758.
[15]
Dissing-Olesen, L., LeDue, J. M., Rungta, R. L., Hefendehl, J. K., Choi, H. B., MacVicar, B. A. Activation of neuronal NMDA receptors triggers transient ATP-mediated microglial process outgrowth. Journal of Neuroscience, 2014, 34(32): 10511–10527.
[16]
Eyo, U. B., Peng, J., Swiatkowski, P., Mukherjee, A., Bispo, A., Wu, L. J. Neuronal hyperactivity recruits microglial processes via neuronal NMDA receptors and microglial P2Y12 receptors after status epilepticus. Journal of Neuroscience, 2014, 34(32): 10528–10540.
[17]
Irino, Y., Nakamura, Y., Inoue, K., Kohsaka, S., Ohsawa, K. Akt activation is involved in P2Y12 receptor-mediated chemotaxis of microglia. Journal of Neuroscience Research, 2008, 86(7): 1511–1519.
[18]
Ohsawa, K., Irino, Y., Sanagi, T., Nakamura, Y., Suzuki, E., Inoue, K., Kohsaka, S. P2Y12 receptor-mediated integrin-β1 activation regulates microglial process extension induced by ATP. Glia, 2010, 58(7): 790–801.
[19]
Madry, C., Kyrargyri, V., Arancibia-Cárcamo, I. L., Jolivet, R., Kohsaka, S., Bryan, R. M., Attwell, D. Microglial ramification, surveillance, and interleukin-1β release are regulated by the two-pore domain K+ channel THIK-1. Neuron, 2018, 97(2): 299–312.e6.
[20]
Swiatkowski, P., Murugan, M., Eyo, U. B., Wang, Y., Rangaraju, S., Oh, S. B., Wu, L. J. Activation of microglial P2Y12 receptor is required for outward potassium currents in response to neuronal injury. Neuroscience, 2016, 318: 22–33.
[21]
Stowell, R. D., Sipe, G. O., Dawes, R. P., Batchelor, H. N., Lordy, K. A., Whitelaw, B. S., Stoessel, M. B., Bidlack, J. M., Brown, E., Sur, M. et al. Noradrenergic signaling in the wakeful state inhibits microglial surveillance and synaptic plasticity in the mouse visual cortex. Nature Neuroscience, 2019, 22(11): 1782–1792.
[22]
Liu, Y. U., Ying, Y. L., Li, Y. J., Eyo, U. B., Chen, T. J., Zheng, J. Y., Umpierre, A. D., Zhu, J., Bosco, D. B., Dong, H. L. et al. Neuronal network activity controls microglial process surveillance in awake mice via norepinephrine signaling. Nature Neuroscience, 2019, 22(11): 1771–1781.
[23]
Suzuki, T., Kohyama, K., Moriyama, K., Ozaki, M., Hasegawa, S., Ueno, T., Saitoe, M., Morio, T., Hayashi, M., Sakuma, H. Extracellular ADP augments microglial inflammasome and NF-κB activation via the P2Y12 receptor. European Journal of Immunology, 2020, 50(2): 205–219.
[24]
Sipe, G. O., Lowery, R. L., Tremblay, M. È., Kelly, E. A., Lamantia, C. E., Majewska, A. K. Microglial P2Y12 is necessary for synaptic plasticity in mouse visual cortex. Nature Communications, 2016, 7: 10905.
[25]
Peng, J. Y., Liu, Y., Umpierre, A. D., Xie, M. L., Tian, D. S., Richardson, J. R., Wu, L. J. Microglial P2Y12 receptor regulates ventral hippocampal CA1 neuronal excitability and innate fear in mice. Molecular Brain, 2019, 12: 71.
[26]
Cserép, C., Pósfai, B., Lénárt, N., Fekete, R., László, Z. I., Lele, Z., Orsolits, B., Molnár, G., Heindl, S., Schwarcz, A. D., et al. Microglia monitor and protect neuronal function through specialized somatic purinergic junctions. Science, 2020, 367(6477): 528–537.
[27]
Maeda, M., Tsuda, M., Tozaki-Saitoh, H., Inoue, K., Kiyama, H. Nerve injury-activated microglia engulf myelinated axons in a P2Y12 signaling-dependent manner in the dorsal horn. Glia, 2010, 58(15): 1838–1846.
[28]
Gu, N., Peng, J. Y., Murugan, M., Wang, X., Eyo, U. B., Sun, D. M., Ren, Y., Dicicco-Bloom, E., Young, W., Dong, H. L. et al. Spinal microgliosis due to resident microglial proliferation is required for pain hypersensitivity after peripheral nerve injury. Cell Reports, 2016, 16(3): 605–614.
[29]
Gu, N., Eyo, U. B., Murugan, M., Peng, J. Y., Matta, S., Dong, H. L., Wu, L. J. Microglial P2Y12 receptors regulate microglial activation and surveillance during neuropathic pain. Brain, Behavior, and Immunity, 2016, 55: 82–92.
[30]
Mo, M. S., Eyo, U. B., Xie, M. L., Peng, J. Y., Bosco, D. B., Umpierre, A. D., Zhu, X. Q., Tian, D. S., Xu, P. Y., Wu, L. J. Microglial P2Y12 receptor regulates seizure-induced neurogenesis and immature neuronal projections. The Journal of Neuroscience, 2019, 39(47): 9453–9464.
[31]
Krasemann, S., Madore, C., Cialic, R., Baufeld, C., Calcagno, N., El Fatimy, R., Beckers, L., O’Loughlin, E., Xu, Y., Fanek, Z. et al. The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases. Immunity, 2017, 47(3): 566–581.e9.
[32]
Koizumi, S., Shigemoto-Mogami, Y., Nasu-Tada, K., Shinozaki, Y., Ohsawa, K., Tsuda, M., Joshi, B. V., Jacobson, K. A., Kohsaka, S., Inoue, K. UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis. Nature, 2007, 446(7139): 1091–1095.
[33]
Neher, J. J., Neniskyte, U., Hornik, T., Brown, G. C. Inhibition of UDP/P2Y6purinergic signaling prevents phagocytosis of viable neurons by activated microglia in vitro and in vivo. Glia, 2014, 62(9): 1463–1475.
[34]
Ito, M., Matsuoka, I. Inhibition of P2Y6 receptor-mediated phospholipase C activation and Ca2+ signalling by prostaglandin E2 in J774 murine macrophages. European Journal of Pharmacology, 2015, 749: 124–132.
[35]
Uesugi, A., Kataoka, A., Tozaki-Saitoh, H., Koga, Y., Tsuda, M., Robaye, B., Boeynaems, J. M., Inoue, K. Involvement of protein kinase D in uridine diphosphate-induced microglial macropinocytosis and phagocytosis. Glia, 2012, 60(7): 1094–1105.
[36]
Xu, Y. T., Hu, W. H., Liu, Y. M., Xu, P. F., Li, Z. C., Wu, R., Shi, X. L., Tang, Y. M. P2Y6 receptor-mediated microglial phagocytosis in radiation-induced brain injury. Molecular Neurobiology, 2016, 53(6): 3552–3564.
[37]
Inoue, K. UDP facilitates microglial phagocytosis through P2Y6 receptors. Cell Adhesion & Migration, 2007, 1(3): 131–132.
[38]
de Simone, R., Niturad, C. E., de Nuccio, C., Ajmone-Cat, M. A., Visentin, S., Minghetti, L. TGF-β and LPS modulate ADP-induced migration of microglial cells through P2Y1 and P2Y12 receptor expression. Journal of Neurochemistry, 2010, 115(2): 450–459.
[39]
Li, H. Q., Chen, C., Dou, Y., Wu, H. J., Liu, Y. J., Lou, H. F., Zhang, J. M., Li, X. M., Wang, H., Duan, S. P2Y4 receptor-mediated pinocytosis contributes to amyloid beta-induced self-uptake by microglia. Molecular and Cellular Biology, 2013, 33(21): 4282–4293.
[40]
Stefani, J., Tschesnokowa, O., Parrilla, M., Robaye, B., Boeynaems, J. M., Acker-Palmer, A., Zimmermann, H., Gampe, K. Disruption of the microglial ADP receptor P2Y13 enhances adult hippocampal neurogenesis. Frontiers in Cellular Neuroscience, 2018, 12: 134. .
[41]
Zhou, R., Xu, T., Liu, X. H., Chen, Y. S., Kong, D. Y., Tian, H., Yue, M. X., Huang, D. J., Zeng, J. W. Activation of spinal dorsal horn P2Y13 receptors can promote the expression of IL-1β and IL-6 in rats with diabetic neuropathic pain. Journal of Pain Research, 2018, 11: 615–628.
[42]
Kyrargyri, V., Madry, C., Rifat, A., Arancibia-Carcamo, I. L., Jones, S. P., Chan, V. T. T., Xu, Y. J., Robaye, B., Attwell, D. P2Y13 receptors regulate microglial morphology, surveillance, and resting levels of interleukin 1β release. Glia, 2020, 68(2): 328–344.
[43]
North, R. A. P2X receptors. Philosophical transactions of the Royal Society of London. Series B, Biological sciences, 2016, 371(1700): 20150427.
[44]
North, R. A. Molecular physiology of P2X receptors. Physiological Reviews, 2002, 82(4): 1013–1067.
[45]
Jarvis, M. F. The neural-glial purinergic receptor ensemble in chronic pain states. Trends in Neurosciences, 2010, 33(1): 48–57.
[46]
Trang, T., Beggs, S., Salter, M. W. ATP receptors gate microglia signaling in neuropathic pain. Experimental Neurology, 2012, 234(2): 354–361.
[47]
Tsuda, M. Microglia in the spinal cord and neuropathic pain. Journal of Diabetes Investigation, 2016, 7(1): 17–26.
[48]
Masuda, T., Iwamoto, S., Yoshinaga, R., Tozaki-Saitoh, H., Nishiyama, A., Mak, T. W., Tamura, T., Tsuda, M., Inoue, K. Transcription factor IRF5 drives P2X4R+-reactive microglia gating neuropathic pain. Nature Communications, 2014, 5: 3771.
[49]
Tsuda, M., Shigemoto-Mogami, Y., Koizumi, S., Mizokoshi, A., Kohsaka, S., Salter, M. W., Inoue, K. P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature, 2003, 424(6950): 778–783.
[50]
Zheng, Z. C., Du, X. J., Zhang, K. G., Wang, X. Y., Chen, Y. X., Kuang, N. F., Fan, T., Sun, B. L. Olfactory ensheathing cell transplantation inhibits P2X4 receptor overexpression in spinal cord injury rats with neuropathic pain. Neuroscience Letters, 2017, 651: 171–176.
[51]
Jin, X. H., Wang, L. N., Zuo, J. L., Yang, J. P., Liu, S. L. P2X4 receptor in the dorsal horn partially contributes to brain-derived neurotrophic factor oversecretion and toll-like receptor-4 receptor activation associated with bone cancer pain. Journal of Neuroscience Research, 2014, 92(12): 1690–1702.
[52]
Almeida, C., DeMaman, A., Kusuda, R., Cadetti, F., Ravanelli, M. I., Queiroz, A. L., Sousa, T. A., Zanon, S., Silveira, L. R., Lucas, G. Exercise therapy normalizes BDNF upregulation and glial hyperactivity in a mouse model of neuropathic pain. PAIN, 2015, 156(3): 504–513.
[53]
Franke, H., Schepper, C., Illes, P., Krügel, U. Involvement of P2X and P2Y receptors in microglial activation in vivo. Purinergic Signalling, 2007, 3(4): 435–445.
[54]
Horvath, R. J., DeLeo, J. A. Morphine enhances microglial migration through modulation of P2X4 receptor signaling. The Journal of Neuroscience, 2009, 29(4): 998–1005.
[55]
Vázquez-Villoldo, N., Domercq, M., Martín, A., Llop, J., Gómez-Vallejo, V., Matute, C. P2X4 receptors control the fate and survival of activated microglia. Glia, 2014, 62(2): 171–184.
[56]
Puchałowicz, K., Tarnowski, M., Baranowska-Bosiacka, I., Chlubek, D., Dziedziejko, V. P2X and P2Y receptors—role in the pathophysiology of the nervous system. International Journal of Molecular Sciences, 2014, 15(12): 23672–23704.
[57]
Gordon, J. L. Extracellular ATP: Effects, sources and fate. The Biochemical Journal, 1986, 233(2): 309–319.
[58]
Witting, A., Walter, L., Wacker, J., Möller, T., Stella, N. P2X7 receptors control 2-arachidonoylglycerol production by microglial cells. Proceedings of the National Academy of Sciences of the United States of America, 2004, 101(9): 3214–3219.
[59]
Masuch, A., Shieh, C. H., van Rooijen, N., van Calker, D., Biber, K. Mechanism of microglia neuroprotection: Involvement of P2X7, TNFα, and valproic acid. Glia, 2016, 64(1): 76–89.
[60]
Parvathenani, L. K., Tertyshnikova, S., Greco, C. R., Roberts, S. B., Robertson, B., Posmantur, R. P2X7 mediates superoxide production in primary microglia and is up-regulated in a transgenic mouse model of Alzheimer's disease. Journal of Biological Chemistry, 2003, 278(15): 13309–13317.
[61]
Sanz, J. M., Virgilio, F. D. Kinetics and mechanism of ATP-dependent IL-1β release from microglial cells. The Journal of Immunology, 2000, 164(9): 4893–4898.
[62]
Yiangou, Y., Facer, P., Durrenberger, P., Chessell, I. P., Naylor, A., Bountra, C., Banati, R. R., Anand, P. COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord. BMC Neurology, 2006, 6: 12.
[63]
Shieh, C. H., Heinrich, A., Serchov, T., van Calker, D., Biber, K. P2X7-dependent, but differentially regulated release of IL-6, CCL2, and TNF-α in cultured mouse microglia. Glia, 2014, 62(4): 592–607.
[64]
Franke, H., Günther, A., Grosche, J., Schmidt, R., Rossner, S., Reinhardt, R., Faber-Zuschratter, H., Schneider, D., Illes, P. P2X7 receptor expression after ischemia in the cerebral cortex of rats. Journal of Neuropathology & Experimental Neurology, 2004, 63(7): 686–699.
[65]
McLarnon, J. G., Ryu, J. K., Walker, D. G., Choi, H. B. Upregulated expression of purinergic P2X7 receptor in alzheimer disease and amyloid-β peptide-treated microglia and in peptide-injected rat hippocampus. Journal of Neuropathology & Experimental Neurology, 2006, 65(11): 1090–1097.
[66]
Li, J., Li, X. N., Jiang, X., Yang, M., Yang, R., Burnstock, G., Xiang, Z. H., Yuan, H. B. Microvesicles shed from microglia activated by the P2X7-p38 pathway are involved in neuropathic pain induced by spinal nerve ligation in rats. Purinergic Signalling, 2017, 13(1): 13–26.
[67]
van Hove, H., Martens, L., Scheyltjens, I., de Vlaminck, K., Pombo Antunes, A. R., de Prijck, S., Vandamme, N., de Schepper, S., van Isterdael, G., Scott, C. L. et al. A single-cell atlas of mouse brain macrophages reveals unique transcriptional identities shaped by ontogeny and tissue environment. Nature Neuroscience, 2019, 22(6): 1021–1035.
[68]
Garré, J. M., Silva, H. M., Lafaille, J. J., Yang, G. P2X7 receptor inhibition ameliorates dendritic spine pathology and social behavioral deficits in Rett syndrome mice. Nature Communications, 2020, 11: 1784.
[69]
Ralevic, V., Burnstock, G. Receptors for purines and pyrimidines. Pharmacological Reviews, 1998, 50(3): 413–492.
[70]
Chen, J. F., Lee, C. F., Chern, Y. Adenosine receptor neurobiology: Overview. International Review of Neurobiology, 2014, 119: 1–49.
[71]
Wollmer, M. A., Lucius, R., Wilms, H., Held-Feindt, J., Sievers, J., Mentlein, R. ATP and adenosine induce ramification of microglia in vitro. Journal of Neuroimmunology, 2001, 115(1–2): 19–27.
[72]
Orr, A. G., Orr, A. L., Li, X. J., Gross, R. E., Traynelis, S. F. Adenosine A2A receptor mediates microglial process retraction. Nature Neuroscience, 2009, 12(7): 872–878.
[73]
Gyoneva, S., Shapiro, L., Lazo, C., Garnier-Amblard, E., Smith, Y., Miller, G. W., Traynelis, S. F. Adenosine A2A receptor antagonism reverses inflammation-induced impairment of microglial process extension in a model of Parkinson's disease. Neurobiology of Disease, 2014, 67: 191–202.
[74]
Trincavelli, M. L., Melani, A., Guidi, S., Cuboni, S., Cipriani, S., Pedata, F., Martini, C. Regulation of A2A adenosine receptor expression and functioning following permanent focal ischemia in rat brain. Journal of Neurochemistry, 2007, 104(2): 479–490.
[75]
Gyoneva, S., Orr, A. G., Traynelis, S. F. Differential regulation of microglial motility by ATP/ADP and adenosine. Parkinsonism & Related Disorders, 2009, 15: S195–S199.
[76]
Fiebich, B. L., Biber, K., Lieb, K., van Calker, D., Berger, M., Bauer, J., Gebicke-Haerter, P. J. Cyclooxygenase-2 expression in rat microglia is induced by adenosine A2a-receptors. Glia, 1996, 18(2): 152–180.
[77]
Saura, J., Angulo, E., Ejarque, A., Casado, V., Tusell, J. M., Moratalla, R., Chen, J. F., Schwarzschild, M. A., Lluis, C., Franco, R. et al. Adenosine A2A receptor stimulation potentiates nitric oxide release by activated microglia. Journal of Neurochemistry, 2005, 95(4): 919–929.
[78]
Teismann, P., Vila, M., Choi, D. K., Tieu, K., Wu, D. C., Jackson-Lewis, V., Przedborski, S. COX-2 and neurodegeneration in Parkinson's disease. Annals of the New York Academy of Sciences, 2003, 991: 272–277.
[79]
Ouyang, X. S., Ghani, A., Malik, A., Wilder, T., Colegio, O. R., Flavell, R. A., Cronstein, B. N., Mehal, W. Z. Adenosine is required for sustained inflammasome activation via the A2A receptor and the HIF-1α pathway. Nature Communications, 2013, 4: 2909.
[80]
Li, Z. H., Li, W., Li, Q., Tang, M. K. Extracellular nucleotides and adenosine regulate microglial motility and their role in cerebral ischemia. Acta Pharmaceutica Sinica B, 2013, 3(4): 205–212.
[81]
Ahmad, S., Fatteh, N., El-Sherbiny, N. M., Naime, M., Ibrahim, A. S., El-Sherbini, A. M., El-Shafey, S. A., Khan, S., Fulzele, S., Gonzales, J. et al. Potential role of A2A adenosine receptor in traumatic optic neuropathy. Journal of Neuroimmunology, 2013, 264(1–2): 54–64.
[82]
Colella, M., Zinni, M., Pansiot, J., Cassanello, M., Mairesse, J., Ramenghi, L., Baud, O. Modulation of microglial activation by adenosine A2a receptor in animal models of perinatal brain injury. Frontiers in Neurology, 2018, 9: 605. .
[83]
Luongo, L., Guida, F., Imperatore, R., Napolitano, F., Gatta, L., Cristino, L., Giordano, C., Siniscalco, D., di Marzo, V., Bellini, G. et al. The A1 adenosine receptor as a new player in microglia physiology. Glia, 2014, 62(1): 122–132.
[84]
Synowitz, M., Glass, R., Färber, K., Markovic, D., Kronenberg, G., Herrmann, K., Schnermann, J., Nolte, C., van Rooijen, N., Kiwit, J. et al. A1 adenosine receptors in microglia control glioblastoma-host interaction. Cancer Research, 2006, 66(17): 8550–8557.
[85]
Tsutsui, S. A1 adenosine receptor upregulation and activation attenuates neuroinflammation and demyelination in a model of multiple sclerosis. Journal of Neuroscience, 2004, 24(6): 1521–1529.
[86]
Terayama, R., Tabata, M., Maruhama, K., Iida, S. A3 adenosine receptor agonist attenuates neuropathic pain by suppressing activation of microglia and convergence of nociceptive inputs in the spinal dorsal horn. Experimental Brain Research, 2018, 236(12): 3203–3213.
[87]
Merighi, S., Borea, P. A., Stefanelli, A., Bencivenni, S., Castillo, C. A., Varani, K., Gessi, S. A2a and a2b adenosine receptors affect HIF-1α signaling in activated primary microglial cells. Glia, 2015, 63(11): 1933–1952.
[88]
Pedata, F., Corsi, C., Melani, A., Bordoni, F., Latini, S. Adenosine extracellular brain concentrations and role of A2A receptors in ischemia. Annals of the New York Academy of Sciences, 2006, 939(1): 74–84.
[89]
van der Putten, C., Zuiderwijk-Sick, E. A., van Straalen, L., de Geus, E. D., Boven, L. A., Kondova, I., IJzerman, A. P., Bajramovic, J. J. Differential expression of adenosine A3 receptors controls adenosine A2A receptor-mediated inhibition of TLR responses in microglia. The Journal of Immunology, 2009, 182(12): 7603–7612.
[90]
Ohsawa, K., Sanagi, T., Nakamura, Y., Suzuki, E., Inoue, K., Kohsaka, S. Adenosine A3 receptor is involved in ADP-induced microglial process extension and migration. Journal of Neurochemistry, 2012, 121(2): 217–227.